Gubra AS (CHIX:GUBRAC) Debt-to-Revenue : 0.35 (As of Dec. 2023)

Gubra AS Debt-to-Revenue Chart

Competitive Comparison of Gubra AS's Debt-to-Revenue

For the Biotechnology subindustry, Gubra AS's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gubra AS's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Gubra AS's Debt-to-Revenue falls into.

Gubra AS Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Gubra AS's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Gubra AS's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

Gubra AS Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gubra AS's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Gubra AS (CHIX:GUBRAC) Business Description